Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership181,025 shares
Latest Disclosed Value $ 1,473,544
Alps Advisors Inc reports 35.67% increase in ownership of NVAX / Novavax, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 181,025 shares of Novavax, Inc. (CH:NVAX) valued at $1,473,544 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 133,432 shares of Novavax, Inc.. This represents a change in shares of 35.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NOVAVAX COM NEW 670002401 181,025 47,593 35.67 1,474 64.40 0.0064
2026-02-12 2025-12-31 13F NOVAVAX COM NEW 670002401 133,432 57,675 76.13 897 36.59 0.0052
2025-11-05 2025-09-30 13F NOVAVAX COM NEW 670002401 75,757 -11,576 -13.26 657 19.27 0.0037
2025-08-11 2025-06-30 13F NOVAVAX COM NEW 670002401 87,333 -26,898 -23.55 550 -24.86 0.0032
2025-04-30 2025-03-31 13F NOVAVAX COM NEW 670002401 114,231 -15,299 -11.81 732 -29.68 0.0042
2025-02-13 2024-12-31 13F NOVAVAX COM NEW 670002401 129,530 129,530 1,041 0.0066
2023-08-14 2023-06-30 13F NOVAVAX COM NEW 670002401 0 -56,775 -100.00 0 -100.00
2023-05-10 2023-03-31 13F NOVAVAX COM NEW 670002401 56,775 3,560 6.69 393 -28.15 0.0035
2023-02-14 2022-12-31 13F NOVAVAX COM NEW 670002401 53,215 10,502 24.59 547 -29.60 0.0049
2022-11-14 2022-09-30 13F NOVAVAX COM NEW 670002401 42,713 -3,642 -7.86 777 -67.41 0.0074
2022-08-15 2022-06-30 13F/A-1 NOVAVAX COM NEW 670002401 46,355 46,355 2,384 0.0232
2022-08-11 2022-06-30 13F NOVAVAX COM NEW 670002401 46,355 46,355 2,384 0.0232
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.